Affordable Access

Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs

Authors
Journal
European Journal of Medicinal Chemistry
0223-5234
Publisher
Elsevier
Volume
62
Identifiers
DOI: 10.1016/j.ejmech.2012.09.017
Keywords
  • Isoflavone Analogs
  • Heck Reaction
  • Synthesis
  • Anti-Hbv Activity
  • Anti-Cancer Activity
Disciplines
  • Design

Abstract

Abstract We have synthesized a series of novel isoflavone analogs and evaluated their anti-HBV and anti-cancer activities in vitro. The bioassays showed that the majority of the resultant compounds exerted inhibitory effects on HBsAg and HBeAg levels, HBV DNA replication, as well as the growth of four human cancer cell lines to various extents, which supported the rationale of the design. In particular, compound 8f showed the highest activity against HBV infection and HBV-related liver cancer. Compound 7l (IC50 = 0.47 μM) also exerted remarkable inhibitory effect on the growth lung cancer cell line A-549.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Nucleotide analogs as novel anti-hepatitis B virus...

on Current opinion in pharmacolog... October 2005

Nucleotide analogs as novel anti-hepatitis B virus...

on Current Opinion in Pharmacolog... Jan 01, 2005

Lesson learned from nature for the development of...

on Current Pharmaceutical Design June 2010

Synthesis of novel 4'α-trifluoromethyl-2'β-C-methy...

on Nucleosides, nucleotides & nuc... 2015
More articles like this..